KR101044437B1 - 5 혈청형 폐렴연쇄구균 피막 폴리사카라이드의 환원적아민화에 의해 수득된 접합체 - Google Patents

5 혈청형 폐렴연쇄구균 피막 폴리사카라이드의 환원적아민화에 의해 수득된 접합체 Download PDF

Info

Publication number
KR101044437B1
KR101044437B1 KR1020057013266A KR20057013266A KR101044437B1 KR 101044437 B1 KR101044437 B1 KR 101044437B1 KR 1020057013266 A KR1020057013266 A KR 1020057013266A KR 20057013266 A KR20057013266 A KR 20057013266A KR 101044437 B1 KR101044437 B1 KR 101044437B1
Authority
KR
South Korea
Prior art keywords
polysaccharide
formula
type
aminated
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020057013266A
Other languages
English (en)
Korean (ko)
Other versions
KR20050093838A (ko
Inventor
노엘 미스트리타
에밀리에 댄비
모니크 모레우
Original Assignee
사노피 파스퇴르
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피 파스퇴르 filed Critical 사노피 파스퇴르
Publication of KR20050093838A publication Critical patent/KR20050093838A/ko
Application granted granted Critical
Publication of KR101044437B1 publication Critical patent/KR101044437B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020057013266A 2003-01-17 2004-01-16 5 혈청형 폐렴연쇄구균 피막 폴리사카라이드의 환원적아민화에 의해 수득된 접합체 Expired - Lifetime KR101044437B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0300488A FR2850106B1 (fr) 2003-01-17 2003-01-17 Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
FR03/00,488 2003-01-17

Publications (2)

Publication Number Publication Date
KR20050093838A KR20050093838A (ko) 2005-09-23
KR101044437B1 true KR101044437B1 (ko) 2011-06-27

Family

ID=32605815

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057013266A Expired - Lifetime KR101044437B1 (ko) 2003-01-17 2004-01-16 5 혈청형 폐렴연쇄구균 피막 폴리사카라이드의 환원적아민화에 의해 수득된 접합체

Country Status (13)

Country Link
US (1) US7812006B2 (cg-RX-API-DMAC7.html)
EP (1) EP1590373B1 (cg-RX-API-DMAC7.html)
KR (1) KR101044437B1 (cg-RX-API-DMAC7.html)
AT (1) ATE520718T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004207647B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0406819B1 (cg-RX-API-DMAC7.html)
CA (1) CA2512847C (cg-RX-API-DMAC7.html)
DK (1) DK1590373T3 (cg-RX-API-DMAC7.html)
FR (1) FR2850106B1 (cg-RX-API-DMAC7.html)
IL (1) IL169689A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA05007533A (cg-RX-API-DMAC7.html)
NZ (1) NZ541254A (cg-RX-API-DMAC7.html)
WO (1) WO2004067574A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2000278267A1 (en) 2000-09-01 2002-03-22 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Vibrio cholerae o139 conjugate vaccines
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
IL308456A (en) 2005-04-08 2024-01-01 Wyeth Llc A multivalent pneumomuroral protein-polysaccharide conjugate preparation
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
US9522382B2 (en) * 2011-09-06 2016-12-20 Biologistics Llc Affinity/lectin chromatography methods
EP2755683B1 (en) * 2011-09-14 2019-04-03 GlaxoSmithKline Biologicals SA Methods for making saccharide-protein glycoconjugates
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
EP3303357B1 (en) 2015-06-08 2021-05-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Vaccines against streptococcus pneumoniae serotype 5
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
IL267709B2 (en) 2016-12-30 2025-04-01 Vaxcyte Inc Polypeptide-antigen conjugates with unnatural amino acids
US20200061542A1 (en) * 2017-02-24 2020-02-27 Merck Sharp & Dohme Corp. Methods for improving filterability of polysaccharide-protein conjugate reactions
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
EP3720483B1 (en) 2017-12-06 2025-11-19 Merck Sharp & Dohme LLC Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
EP3897705A2 (en) 2018-12-19 2021-10-27 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
US20230405137A1 (en) * 2020-11-10 2023-12-21 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN120607643B (zh) * 2025-07-24 2026-05-12 江苏中慧元通生物科技股份有限公司 一种肺炎球菌单价多糖的纯化工艺

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051339A1 (fr) * 1997-05-14 1998-11-19 Pasteur Merieux Serums & Vaccins Composition vaccinale multivalente a porteur mixte
WO2000055210A1 (en) * 1999-03-12 2000-09-21 Aventis Pasteur Method for the reductive amination of polysaccharides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
FR2682388B1 (fr) 1991-10-10 1995-06-09 Pasteur Merieux Serums Vacc Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
AU693098B2 (en) 1993-06-09 1998-06-25 Connaught Laboratories Limited Tandem synthetic HIV-1 peptides
CA2366152A1 (en) 1999-03-19 2000-09-28 Smithkline Beecham Biologicals S.A. Streptococcus pneumoniae vaccine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051339A1 (fr) * 1997-05-14 1998-11-19 Pasteur Merieux Serums & Vaccins Composition vaccinale multivalente a porteur mixte
WO2000055210A1 (en) * 1999-03-12 2000-09-21 Aventis Pasteur Method for the reductive amination of polysaccharides

Also Published As

Publication number Publication date
BRPI0406819B8 (cg-RX-API-DMAC7.html) 2021-05-25
IL169689A0 (en) 2007-07-04
EP1590373A1 (fr) 2005-11-02
BRPI0406819A (pt) 2005-12-27
CA2512847C (en) 2012-08-21
US20040170638A1 (en) 2004-09-02
EP1590373B1 (fr) 2011-08-17
DK1590373T3 (da) 2011-12-05
NZ541254A (en) 2008-07-31
US7812006B2 (en) 2010-10-12
BRPI0406819B1 (pt) 2017-01-03
FR2850106A1 (fr) 2004-07-23
KR20050093838A (ko) 2005-09-23
CA2512847A1 (en) 2004-08-12
WO2004067574A1 (fr) 2004-08-12
MXPA05007533A (es) 2005-12-05
AU2004207647B2 (en) 2010-07-01
ATE520718T1 (de) 2011-09-15
AU2004207647A1 (en) 2004-08-12
FR2850106B1 (fr) 2005-02-25

Similar Documents

Publication Publication Date Title
JP4290766B2 (ja) 多糖―ペプチド複合体
KR20050093838A (ko) 5 혈청형 폐렴연쇄구균 피막 폴리사카라이드의 환원적아민화에 의해 수득된 접합체
EP1109576B1 (en) Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
AU661071B2 (en) Oligoside derived from an antigen polyoside obtained from a pathogenic agent
US12465632B2 (en) Purified capsular polysaccharides of Streptococcus pneumoniae
US20140341909A1 (en) Conjugation of biomolecules using diels-alder cycloaddition
JP2020523323A (ja) 改善された免疫原性及び結合活性を提供する2価又は多価コンジュゲート多糖を含む多価コンジュゲートワクチン
JP2020504760A (ja) 非天然アミノ酸とのポリペプチド抗原接合体
JPH11506491A (ja) 修飾したメニンゴコッカスのポリサッカライドを結合したワクチン
CN103083652B (zh) 一种以异型双功能试剂为连接桥的脑膜炎多糖结合疫苗及其制备方法
US12053515B2 (en) Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F
KR101266552B1 (ko) 그룹 y 수막염균에 대한 백신 및 그의 수막염균성 조합
US5952454A (en) Linking compounds useful for coupling carbohydrates to amine-containing carriers
US11097000B2 (en) Klebsiella pneumoniae capsule polysaccharide vaccines
JP2023549736A (ja) コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
JP5689064B2 (ja) 精製方法
TWI910585B (zh) 包含經結合之莢膜醣抗原的免疫原組合物及其用途
US20020068818A1 (en) Conjugation of biomolecules using diels-alder cycloaddition
CN121057590A (zh) 包含缀合荚膜糖抗原的免疫原性组合物及其用途
CN115721709A (zh) 一种肺炎球菌结合疫苗制备方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20140609

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20150519

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

FPAY Annual fee payment

Payment date: 20160517

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

FPAY Annual fee payment

Payment date: 20170522

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

FPAY Annual fee payment

Payment date: 20180516

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20190515

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PC1801 Expiration of term

St.27 status event code: N-4-6-H10-H14-oth-PC1801

Not in force date: 20240117

Ip right cessation event data comment text: Termination Category : EXPIRATION_OF_DURATION

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

R13 Change to the name of applicant or owner recorded

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R13-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)